Accel Wealth Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-426
Closed -$23.2K 749
2023
Q1
$23.2K Hold
426
0.01% 664
2022
Q4
$20.6K Hold
426
0.01% 537
2022
Q3
$17K Hold
426
0.01% 612
2022
Q2
$22K Hold
426
0.01% 524
2022
Q1
$22K Sell
426
-250
-37% -$12.9K 0.01% 538
2021
Q4
$34K Hold
676
0.02% 456
2021
Q3
$33K Hold
676
0.02% 400
2021
Q2
$36K Sell
676
-100
-13% -$5.22K 0.02% 404
2021
Q1
$38K Sell
776
-100
-11% -$4.8K 0.03% 372
2020
Q4
$43K Buy
+876
New +$43.2K 0.04% 324

Other funds holding SNY

Accel Wealth Management's SNY Position: Q2 2023 in Review

Accel Wealth Management sold out of Sanofi (SNY) in Q2 2023, closing a stake of 426 shares — an estimated $23.2K sold.

Accel Wealth Management first reported a position in SNY in Q4 2020 and held it in 10 quarters. The position peaked at $43K in Q4 2020. 672 funds tracked by Wall St. Rank hold SNY as of Q2 2023.

  • Accel Wealth Management reported no remaining Sanofi position as of Q2 2023 after selling out during the quarter.
  • Accel Wealth Management sold 426 Sanofi shares in Q2 2023, an estimated $23.2K.
  • Accel Wealth Management first reported a position in Sanofi in Q4 2020 and held it in 10 quarters.
  • Accel Wealth Management's Sanofi position peaked at $43K in Q4 2020.
  • 672 funds tracked by Wall St. Rank held Sanofi as of Q2 2023.

Based on Accel Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.